The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Stem Cell Manufacturing Market Research Report 2024

Global Stem Cell Manufacturing Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1892695

No of Pages : 95

Ask Your Query

Synopsis

Large-scale manufacturing of human stem cells for therapeutic use is a leap in technology and science for the current biotechnology industry.

The global Stem Cell Manufacturing market was valued at US$ 12550 million in 2023 and is anticipated to reach US$ 16930 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.

North American market for Stem Cell Manufacturing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Stem Cell Manufacturing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Stem Cell Manufacturing in Pharmaceutical and Biotechnology Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Stem Cell Manufacturing include Thermo Fisher, Merck Group, Becton Dickinson, Bio-Rad, Miltenyi Biotec, Takara Bio, STEMCELL, Pharmicell and Osiris, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Stem Cell Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cell Manufacturing.

Report Scope

The Stem Cell Manufacturing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Stem Cell Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Stem Cell Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company (Partial List):

  • Thermo Fisher
  • Merck Group
  • Becton Dickinson
  • Bio-Rad
  • Miltenyi Biotec
  • Takara Bio
  • STEMCELL
  • Pharmicell
  • Osiris
  • Anterogen
  • Cellular Dynamics
  • MEDIPOST
  • Lonza
  • Holostem
  • Pluristem

Segment by Type

  • Product
  • Services

Segment by Application

  • Pharmaceutical and Biotechnology Companies
  • Cell Banks and Tissue Banks
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Stem Cell Manufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stem Cell Manufacturing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Product
1.2.3 Services
1.3 Market by Application
1.3.1 Global Stem Cell Manufacturing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Cell Banks and Tissue Banks
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Stem Cell Manufacturing Market Perspective (2019-2030)
2.2 Stem Cell Manufacturing Growth Trends by Region
2.2.1 Global Stem Cell Manufacturing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Stem Cell Manufacturing Historic Market Size by Region (2019-2024)
2.2.3 Stem Cell Manufacturing Forecasted Market Size by Region (2025-2030)
2.3 Stem Cell Manufacturing Market Dynamics
2.3.1 Stem Cell Manufacturing Industry Trends
2.3.2 Stem Cell Manufacturing Market Drivers
2.3.3 Stem Cell Manufacturing Market Challenges
2.3.4 Stem Cell Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stem Cell Manufacturing Players by Revenue
3.1.1 Global Top Stem Cell Manufacturing Players by Revenue (2019-2024)
3.1.2 Global Stem Cell Manufacturing Revenue Market Share by Players (2019-2024)
3.2 Global Stem Cell Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Stem Cell Manufacturing Revenue
3.4 Global Stem Cell Manufacturing Market Concentration Ratio
3.4.1 Global Stem Cell Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stem Cell Manufacturing Revenue in 2023
3.5 Stem Cell Manufacturing Key Players Head office and Area Served
3.6 Key Players Stem Cell Manufacturing Product Solution and Service
3.7 Date of Enter into Stem Cell Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Stem Cell Manufacturing Breakdown Data by Type
4.1 Global Stem Cell Manufacturing Historic Market Size by Type (2019-2024)
4.2 Global Stem Cell Manufacturing Forecasted Market Size by Type (2025-2030)
5 Stem Cell Manufacturing Breakdown Data by Application
5.1 Global Stem Cell Manufacturing Historic Market Size by Application (2019-2024)
5.2 Global Stem Cell Manufacturing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Stem Cell Manufacturing Market Size (2019-2030)
6.2 North America Stem Cell Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Stem Cell Manufacturing Market Size by Country (2019-2024)
6.4 North America Stem Cell Manufacturing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Stem Cell Manufacturing Market Size (2019-2030)
7.2 Europe Stem Cell Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Stem Cell Manufacturing Market Size by Country (2019-2024)
7.4 Europe Stem Cell Manufacturing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Stem Cell Manufacturing Market Size (2019-2030)
8.2 Asia-Pacific Stem Cell Manufacturing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Stem Cell Manufacturing Market Size by Region (2019-2024)
8.4 Asia-Pacific Stem Cell Manufacturing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Stem Cell Manufacturing Market Size (2019-2030)
9.2 Latin America Stem Cell Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Stem Cell Manufacturing Market Size by Country (2019-2024)
9.4 Latin America Stem Cell Manufacturing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Stem Cell Manufacturing Market Size (2019-2030)
10.2 Middle East & Africa Stem Cell Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Stem Cell Manufacturing Market Size by Country (2019-2024)
10.4 Middle East & Africa Stem Cell Manufacturing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Detail
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher Stem Cell Manufacturing Introduction
11.1.4 Thermo Fisher Revenue in Stem Cell Manufacturing Business (2019-2024)
11.1.5 Thermo Fisher Recent Development
11.2 Merck Group
11.2.1 Merck Group Company Detail
11.2.2 Merck Group Business Overview
11.2.3 Merck Group Stem Cell Manufacturing Introduction
11.2.4 Merck Group Revenue in Stem Cell Manufacturing Business (2019-2024)
11.2.5 Merck Group Recent Development
11.3 Becton Dickinson
11.3.1 Becton Dickinson Company Detail
11.3.2 Becton Dickinson Business Overview
11.3.3 Becton Dickinson Stem Cell Manufacturing Introduction
11.3.4 Becton Dickinson Revenue in Stem Cell Manufacturing Business (2019-2024)
11.3.5 Becton Dickinson Recent Development
11.4 Bio-Rad
11.4.1 Bio-Rad Company Detail
11.4.2 Bio-Rad Business Overview
11.4.3 Bio-Rad Stem Cell Manufacturing Introduction
11.4.4 Bio-Rad Revenue in Stem Cell Manufacturing Business (2019-2024)
11.4.5 Bio-Rad Recent Development
11.5 Miltenyi Biotec
11.5.1 Miltenyi Biotec Company Detail
11.5.2 Miltenyi Biotec Business Overview
11.5.3 Miltenyi Biotec Stem Cell Manufacturing Introduction
11.5.4 Miltenyi Biotec Revenue in Stem Cell Manufacturing Business (2019-2024)
11.5.5 Miltenyi Biotec Recent Development
11.6 Takara Bio
11.6.1 Takara Bio Company Detail
11.6.2 Takara Bio Business Overview
11.6.3 Takara Bio Stem Cell Manufacturing Introduction
11.6.4 Takara Bio Revenue in Stem Cell Manufacturing Business (2019-2024)
11.6.5 Takara Bio Recent Development
11.7 STEMCELL
11.7.1 STEMCELL Company Detail
11.7.2 STEMCELL Business Overview
11.7.3 STEMCELL Stem Cell Manufacturing Introduction
11.7.4 STEMCELL Revenue in Stem Cell Manufacturing Business (2019-2024)
11.7.5 STEMCELL Recent Development
11.8 Pharmicell
11.8.1 Pharmicell Company Detail
11.8.2 Pharmicell Business Overview
11.8.3 Pharmicell Stem Cell Manufacturing Introduction
11.8.4 Pharmicell Revenue in Stem Cell Manufacturing Business (2019-2024)
11.8.5 Pharmicell Recent Development
11.9 Osiris
11.9.1 Osiris Company Detail
11.9.2 Osiris Business Overview
11.9.3 Osiris Stem Cell Manufacturing Introduction
11.9.4 Osiris Revenue in Stem Cell Manufacturing Business (2019-2024)
11.9.5 Osiris Recent Development
11.10 Anterogen
11.10.1 Anterogen Company Detail
11.10.2 Anterogen Business Overview
11.10.3 Anterogen Stem Cell Manufacturing Introduction
11.10.4 Anterogen Revenue in Stem Cell Manufacturing Business (2019-2024)
11.10.5 Anterogen Recent Development
11.11 Cellular Dynamics
11.11.1 Cellular Dynamics Company Detail
11.11.2 Cellular Dynamics Business Overview
11.11.3 Cellular Dynamics Stem Cell Manufacturing Introduction
11.11.4 Cellular Dynamics Revenue in Stem Cell Manufacturing Business (2019-2024)
11.11.5 Cellular Dynamics Recent Development
11.12 MEDIPOST
11.12.1 MEDIPOST Company Detail
11.12.2 MEDIPOST Business Overview
11.12.3 MEDIPOST Stem Cell Manufacturing Introduction
11.12.4 MEDIPOST Revenue in Stem Cell Manufacturing Business (2019-2024)
11.12.5 MEDIPOST Recent Development
11.13 Lonza
11.13.1 Lonza Company Detail
11.13.2 Lonza Business Overview
11.13.3 Lonza Stem Cell Manufacturing Introduction
11.13.4 Lonza Revenue in Stem Cell Manufacturing Business (2019-2024)
11.13.5 Lonza Recent Development
11.14 Holostem
11.14.1 Holostem Company Detail
11.14.2 Holostem Business Overview
11.14.3 Holostem Stem Cell Manufacturing Introduction
11.14.4 Holostem Revenue in Stem Cell Manufacturing Business (2019-2024)
11.14.5 Holostem Recent Development
11.15 Pluristem
11.15.1 Pluristem Company Detail
11.15.2 Pluristem Business Overview
11.15.3 Pluristem Stem Cell Manufacturing Introduction
11.15.4 Pluristem Revenue in Stem Cell Manufacturing Business (2019-2024)
11.15.5 Pluristem Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock